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antiviral-directed immune response, are under investigation in
experimental and clinical studies.70,114,136,137 Because of the low
rate of diagnosis, multi-centre collaborations with standardized
evaluations and treatment protocols, mechanistically oriented
registries, and core molecular diagnostic facilities will be needed.
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A 65-year-old male patient with typical chest pain
underwent low-dose coronary computed tomo-
graphic (CT) angiography (CCTA) with 1.4 mSv for
evaluation of coronary artery disease (CAD). Panel
A shows a curved multiplanar reformation of the
left circumflex artery with a high-grade stenosis
(white arrow) in the large first obtuse marginal
branch (OM1). Subsequently, a stress cardiac mag-
netic resonance perfusion imaging (CMR) (adenosine
140 mg/kg/min, 0.1 mmol/kg Gadobutrolum,
kt-SENSE) was performed with a new sequence
allowing three-dimensional (3D) perfusion assess-
ment. This revealed a lateral perfusion defect, invol-
ving 13% of the left ventricular myocardium (Panel
B, white arrowheads). The 3D hybrid CMR/CCTA
(obtained using PMOD Technologies Ltd and
CardIQ Fusion, GE Healthcare) showed a perfect
match of the perfusion defect (white arrowheads)
and the culprit lesion (white arrow) (Panel C), docu-
menting a prognostically important finding requiring
revascularization. A 50% stenosis of the proximal
left anterior descending artery was not associated
with any perfusion defect on 3D hybrid CMR/CCTA. Finally, the patient underwent invasive coronary angiography confirming a sub-
total occlusion of the OM1 (Panel D, white arrow) which was successfully revascularized. On clinical follow-up, the patient was well
and reported no further anginal episodes. To our knowledge, this is the first report on 3D CMR/CT hybrid imaging integrating full-
coverage perfusion information from 3D stress CMR and anatomical information from low-dose CCTA. By spatial colocalization of
complementary data sets, hybrid 3D CMR/CT imaging may help to guide revascularization strategies in CAD patients. This latest tech-
nical advancement is an important further step in the attempt to reduce radiation burden in non-invasive hybrid imaging (cumulative
radiation dose 1.4 mSv).
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2011. For permissions please email: journals.permissions@oup.com
The management of myocarditis 2625
